10-Q/A Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2011

Filing Information

Form Type	10-Q/A
Accession Number	`0001144204-11-050273`
Period End Date	20110630
Filing Date	20110829
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	bpth-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 51 Cash Flow Statement 55

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$602.42K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$567.25K	USD	Point-in-time
Cash	`Cash`	$238.56K	USD	Point-in-time
Cash	`Cash`	$1.22M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Grants receivable	`ReceivablesNetCurrent`	$244.48K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$88.40K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$72.99K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$45.15K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$644.44K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	56.15M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.40M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.27M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.40M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	56.15M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$3.08M	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$3.04M	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	928,667.00	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$579.75K	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$684.23K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.40M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.46M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.11M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.66M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$24.20K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$88.40K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$146.53K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$84.14K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$74.22K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$220.72K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$246.76K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$220.72K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$246.76K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 56,146,296 and 49,400,605 shares issued and outstanding as of 6/30/11 and 12/31/10, respectively	`CommonStockValue`	$56.15K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 56,146,296 and 49,400,605 shares issued and outstanding as of 6/30/11 and 12/31/10, respectively	`CommonStockValue`	$49.40K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$11.63M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$9.72M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$278.60K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$7.19M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$8.24M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.86M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.44M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.66M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.11M	USD	Point-in-time

Income Statement 51 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	17 Qtrs
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	2 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$674.81K	USD	2 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$296.03K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$5.52M	USD	17 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$566.58K	USD	2 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$324.57K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$463.77K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$8.56M	USD	17 Qtrs
Total operating expense	`OperatingExpenses`	$1.06M	USD	2 Qtrs
Total operating expense	`OperatingExpenses`	$426.83K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$918.33K	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-463.77K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.06M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-8.56M	USD	17 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-426.83K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-918.33K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$314.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.30K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.11K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.05K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$74.70K	USD	17 Qtrs
Other income	`OtherNonoperatingIncome`	$244.48K	USD	17 Qtrs
Other expense	`OtherNonoperatingExpense`	$293.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$3.17K	USD	17 Qtrs
Other expense	`OtherNonoperatingExpense`	$91.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$467.00	USD	2 Qtrs
Other expense	`OtherNonoperatingExpense`	$271.00	USD	2 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$1.02K	USD	1 Quarter
Total Other Income	`NonoperatingIncomeExpense`	$316.01K	USD	17 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$579.00	USD	2 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$21.00	USD	1 Quarter
Total Other Income	`NonoperatingIncomeExpense`	$1.03K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-426.81K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.06M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-8.24M	USD	17 Qtrs
Net Loss	`NetIncomeLoss`	$-917.75K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-462.75K	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.20	USD	17 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	51.65M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	47.09M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	41.53M	shares	17 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	50.52M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	47.57M	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-426.81K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.06M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.24M	USD	17 Qtrs
Net loss	`NetIncomeLoss`	$-917.75K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-462.75K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$96.01K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$104.47K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$684.23K	USD	17 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$300.00K	USD	17 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$240.66K	USD	2 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$2.81M	USD	17 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$286.66K	USD	2 Qtrs
Grants receivable	`IncreaseDecreaseInReceivables`	$-244.48K	USD	2 Qtrs
Drug product for testing	`IncreaseDecreaseInInventories`	$-88.40K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$45.15K	USD	17 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$28.27K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-27.85K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-26.04K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$147.94K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$220.72K	USD	17 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-375.65K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-415.41K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.27M	USD	17 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$92.19K	USD	2 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$727.20K	USD	17 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$37.55K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-727.20K	USD	17 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.55K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-92.19K	USD	2 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	17 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	17 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$542.78K	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.40M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.80M	USD	17 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$542.78K	USD	2 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.40M	USD	2 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.22M	USD	17 Qtrs
NET INCREASE/(DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$983.09K	USD	2 Qtrs
NET INCREASE/(DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$35.17K	USD	2 Qtrs
NET INCREASE/(DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$1.22M	USD	17 Qtrs
Cash, beginning of period	`Cash`	$602.42K	USD	Point-in-time
Cash, beginning of period	`Cash`	$567.25K	USD	Point-in-time
Cash, beginning of period	`Cash`	$238.56K	USD	Point-in-time
Cash, beginning of period	`Cash`	$1.22M	USD	Point-in-time
Cash, end of period	`Cash`	$602.42K	USD	Point-in-time
Cash, end of period	`Cash`	$567.25K	USD	Point-in-time
Cash, end of period	`Cash`	$238.56K	USD	Point-in-time
Cash, end of period	`Cash`	$1.22M	USD	Point-in-time
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	17 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	17 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	17 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.